No Data
No Data
No Data
No Data
No Data
Zhongsheng Beikong Biotechnology (08247) announced its 2023 annual results. Shareholders should account for a loss of 11.648 million yuan
Zhongsheng Beikong Biotechnology (08247) announced its annual results for the year ended December 31, 2023, with revenue reaching...
Zhitong FinanceMar 28 07:31
BIOSINO BIO-TEC: Annual Report 2023
Futu NewsMar 28 06:18 · Announcements
BIOSINO BIO-TEC: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Futu NewsMar 28 06:14 · Announcements
Zhongsheng Beijing Holdings Biotechnology (08247) issued a profit warning. The net loss for the year is expected to increase from 18 million yuan to 22 million yuan over the same period last year
According to the Zhitong Finance App, Zhongsheng Beijing Holdings Biotechnology (08247) issued an announcement. It is expected that the Group will have a net loss of RMB 18 million to RMB 22 million for the year ended December 31, 2023, while net profit of about RMB 14.202 million for the year ended December 31, 2022. According to the announcement, the expected losses during the reporting period were mainly due to changes in domestic and foreign public health prevention and control policies, a decline in market demand; and a decrease in the Group's gross profit due to falling product prices due to centralized procurement in the industry; and the Group's superior products (such as flow cytometry and
Zhitong FinanceMar 18 18:43
BIOSINO BIO-TEC: PROFIT WARNING
Futu NewsMar 18 18:41 · Announcements
A major favorable raid, and the 1.6 trillion innovative drug sector is booming!
The advantage suddenly “smashed” into the pharmaceutical sector!
券商中國Mar 13 21:18
No Data
No Data